I-AHCC (i-hexose esebenzayo idibeneyo) yinto engokwemvelo ekhishwe kwiintlobo ezithile ze-basidiomycetes (iklasi yama-mushroom equka i-shiitake). Ifumaneka kwifomu yokuxhaswa, i-AHCC yaziwa ngokuba yinto elwa ne-antioxidant. Nangona uphando lweempembelelo zezempilo ze-AHCC aluphelelanga, abacebisi bathi ukuthabatha i-AHCC kunokuvelisa iintlobo zeempatho zezempilo.
Ukusetyenziswa kweAHCC
Ngenye iyeza, i-AHCC kuthiwa ivuselele i-immune system kwaye ikhulise ukhuselo lwakho malunga nokusuleleka kwintsholongwane, kuquka umkhuhlane kunye nokubandayo . Abaninzi abancedisayo bacebisa ukuba i-AHCC inokukunceda ukukhusela umhlaza kunye nokunciphisa iziphumo zechemotherapy. Ukongeza, i-AHCC kuthiwa inokunceda ukukhusela isifo senhliziyo nokuphatha i-hepatitis.
Izinzuzo zezeMpilo ze-AHCC
Kuze kube ngoku, ezimbalwa iimvavanyo zekliniki ziye zavavanya iziphumo zempilo ze-AHCC. Sekunjalo, uphando olusenyakatho lubonisa ukuba i-AHCC inokunikela ngezibonelelo ezithile zezempilo. Nanku ukukhangela kwiziphumo eziliqela eziphambili eziphando olukhoyo:
1) Inkqubo yokuzikhusela
I-AHCC inokunceda ukukhulisa i-immunity, ngokubhekiselele kwilingo elincinci lonyango ka-2008 kwiNutrition and Cancer . Kuhlolisiso, amavolontiya angama-21 anempilo athatha i-AHCC okanye i-placebo yonke imihla kwiiveki ezine. Ekupheleni kokufunda, amalungu eqela le-AHCC abonise ukwanda okukhulu kakhulu kwinani lamaseli e-dendritic (uhlobo lweseli echaphazelekayo kwimpendulo yomzimba).
2) Imiphumo yecandelo le-Chemotherapy Side Effects
Uphando olusekelwe kwizilwanyana lubonisa ukuba i-AHCC inokunceda ukunciphisa imiphumo ethile yechemotherapy. Ngokomzekelo, kwingxelo ka-2009 evela kwi- Journal of Experimental Therapeutics kunye ne-Oncology , izazinzulu ziye zafumanisa ukuba ukuphatha iigundane nge-AHCC kwabanceda bawakhusele umonakalo wesibindi kunye nomnxeba we-bone.
Nangona kunjalo, kungekudala ukuxelela ukuba i-AHCC inokunceda ekunciphiseni imiphumo yechemotherapy kubantu.
3) I cancer
I-AHCC inokunceda ukukhusela ukuphuhliswa komhlaza, ngokuphathelele kwisifundo se-2006 esekelwe kwisilwanyana kwi- Cancer Immunology ne-Immunotherapy . Kuvavanyo olubandakanya iigundane ezingenayo iiseli zomhlaza, ukwelashwa kwe-AHCC kwandise kakhulu impendulo yomzimba kunye nokulibazisa ukuphuhliswa kwesisu.
4) Izifo ezithintekayo zezifo
I-AHCC ibonisa isithembiso ekwenzeni unyango oluvuthayo. Ngophando lwama-2007 kuma-rats (I- Journal of Nutrition ), abaphandi bafumene ukuba i-AHCC incede ekunciphiseni ukuvutha nokunyusa amanqaku amaninzi empilo yeekoloni kwiirati ezine- colitis .
5) I-Flu
Kwiimvavanyo kwiimicebe, izazinzulu ziye zabonisa ukuba i-AHCC inokukunceda ukuhlaziya iimpendulo zokuzivikela komzimba kwisifo sosuleleko. Ngokomzekelo, kwisifundo se-2006 kwi- Journal of Nutrition , i-AHCC yabonakala ukunciphisa ubunzima bokusuleleka kwintsholongwane kunye nokunyusa umsebenzi kwimizimba yokubulala yendalo (umdlali oyintloko kwimpendulo ye-immune).
Imijelo
Akuncinci owaziwayo malunga nokukhuselwa kokusetyenziswa kwexesha elide le-AHCC. Nangona kunjalo, kukho inkxalabo yokuba i-AHCC ingabangela imiphumo emibi, kuquka uhudo kunye nokubetha.
Kuphi ukuwufumana
Ukufumaneka ngokubanzi ekuthengeni i-intanethi, izongezo ze-AHCC zithengiswa kwiindawo ezininzi zokutya zendalo kunye nakwiivenkile ezikhethekileyo kwizibonelelo zokutya.
Ukusebenzisa i-AHCC yezeMpilo
Ngenxa yokungabikho kokuxhasa uphando, kungekudala ukukhuthaza i-AHCC nayiphi na imeko yempilo. Ingakumbi, akukho ubungqina obaneleyo bokuxhasa ibango lokuba i-AHCC inokuthintela umdlavuza. Ukunciphisa ingozi yomhlaza wakho, iNational Cancer Institute ikucebisa ukuba ugweme ukubhema nokubhema; ukunciphisa ukuvezwa kwakho kwimizila, kwaye uhlolwe izimo zangaphambili zomhlaza. Ukulandela ukutya okunempilo, ukusetyenziswa rhoqo kunye nokugcina isisindo esifanayo kunokunceda ukunqanda umdlavuza.
Ukuba ucinga ngokusetyenziswa kwe-AHCC yesimo esingapheliyo, qiniseka ukuba udibane nodokotela wakho.
Ukuziphathela imeko engapheliyo kunye ne-AHCC kwaye ukuphepha okanye ukulibazisa ukunakekelwa okuqhelekileyo kunokuba nemiphumo emibi.
Imithombo
I-Daddaoua A, uMartínez-Plata E, uLópez-Posadas R, i-Vieites JM, uGonzález M, i-Requena P, uZarzuelo A, uSerárez MD, i-Medina FS, uMartínez-Augustin O. "I-hexose esebenzayo ehambelanayo ibonakala njenge-prebiotics Iilwanyana ezine-hapten-incuted colitis. " J Nutriti. 2007 ngoMeyi; 137 (5): 1222-8.
I-Gao Y, i-Zhang D, i-Sun B, i- Fujii H, i-Kosuna K, i-Yin Z. "I-hexose esebenzayo ehlanganisiweyo yenza ngcono ukuxilongwa kwe-tumor ngokulawula izimpendulo zomzimba zomntu ezingahambiyo kunye nezilungelelaniso." I-Immunol Immunol. 2006 Oct; 55 (10): 1258-66.
National Cancer Institute. Inkcazo yokuLungisa umdlavuza. Kugqitywe ngokugqibela ngoFebruwari 13, 2012.
Nogusa S, Gerbino J, Ritz BW. Ukuxhaswa kwe-dose ephantsi kunye ne-hexose esebenzayo idibeneyo iphucula impendulo yokhuselo lomzimba kwintsholongwane ekhuselekileyo kwi-C57BL / 6. Isondlo seMveliso. 2009 Feb; 29 (2): 139-43.
Ritz BW, uNogusa S, uAckerman EA, Gardner EM. "Ukuncedisa kunye ne-hexose esebenzayo idibeneyo yandisa i-immune response response of souris to infections." J Nutriti. 2006 Nov; 136 (11): 2868-73.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. "Ukunciphisa i-hexose esebenzayo (i-AHCC) kwimiphumo echaphazela iziyobisi ezibangelwa iziyobisi kwiimvenge ezingenayo i-tumor." J Exp Ther Oncol. 2009; 8 (1): 43-51.
Takahashi J, Takai S, Kwon AH, Kamiyama Y. "Imiphumo ye-immunological effect ye-hexose esebenzisanayo (AHCC) kumavolontiya aphilileyo: i-double-blind, ityala elilawulwa yi-placebo. " Cancer Cancer. 2008; 60 (5): 643-51.